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Abstract
Background: Passive joint mobilisation is a technique frequently used by physiotherapists to
reduce pain, improve joint movement and facilitate a return to activities after injury, but its use after
ankle fracture is currently based on limited evidence. The primary aim of this trial is to determine
if adding joint mobilisation to a standard exercise programme is effective and cost-effective after
cast immobilisation for ankle fracture in adults.
Methods/Design: Ninety participants will be recruited from the physiotherapy departments of
three teaching hospitals and randomly allocated to treatment or control groups using a concealed
procedure. All participants will perform an exercise programme. Participants in the treatment
group will also receive joint mobilisation twice a week for four weeks. Blinded follow-up
assessments will be conducted four, 12 and 24 weeks after randomisation. The primary outcome
measures will be the Lower Extremity Functional Scale and the Assessment of Quality of Life.
Secondary outcomes will include measures of impairments, activity limitation and participation.
Data on the use of physiotherapy services and participants' out-of-pocket costs will be collected
for the cost-effective and cost-utility analyses. To test the effects of treatment, between-group
differences will be examined with analysis of covariance using a regression approach. The primary
conclusions will be based on the four-week follow-up data.
Discussion: This trial incorporates features known to minimise bias. It uses a pragmatic design to
reflect clinical practice and maximise generalisability. Results from this trial will contribute to an
evidence-based approach for rehabilitation after ankle fracture.
Background
Ankle fracture refers to fracture of the medial or lateral
malleolus or the distal tibia or fibula [1-4]. The incidence
is between 107 and 184 per 100,000 person-years [5-8],
making it one of the most common lower limb fractures
[9,10]. It is usually caused by low-velocity trauma such as
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falls, twisting injuries and sports injuries [6-8], and there-
fore is prevalent in not only the older, but also the young
and active population [6,8]. Orthopaedic management in
adults with ankle fracture may involve reduction, surgical
fixation, and immobilisation for six to 12 weeks depend-
ing on the severity of the fracture [3,4,11-13]. Not surpris-
ingly, fracture severity has been reported to influence
functional outcomes after ankle fracture [9,14,15].
Physiotherapists often contribute to the rehabilitation of
ankle fracture, which typically starts soon after the period
of immobilisation. Due to effects of the fracture and the
subsequent immobilisation, most people experience
pain, swelling, stiffness, muscle atrophy and decreased
muscle torque at the ankle following cast removal [16-
19]. Consequently, they complain of limitations in activ-
ities involving the lower limb, such as stair climbing and
walking [18], and reduced participation in work and rec-
reation [20-22].
Passive joint mobilisation is a technique commonly used
by physiotherapists to address the problems of pain and
joint stiffness, in order to allow an earlier return to activi-
ties. It involves the physiotherapist manually gliding the
articular surfaces of a joint to produce oscillatory move-
ments [23]. It has been proposed that manual therapy
such as joint mobilisation produces analgesic effects and
increases elasticity of joint structures through interactions
at the local, central nervous system and psychological lev-
els [24]. These hypotheses are yet to be validated [25].
Research to-date indicates that the analgesic effect of
peripheral joint mobilisation may be short lasting [26], is
not mediated by endorphins [27], and can been seen with
concurrent excitation of the sympathetic nervous system
[28,29].
The effectiveness of joint mobilisation after post-fracture
immobilisation has been investigated in a small number
of trials with contrasting results. Randall et al [30] showed
that in patients with metacarpophalangeal fracture, mobi-
lisation and exercise led to a greater increase in joint
movement than exercise alone. Coyle and Robertson [31]
reported that mobilisation of the wrist improved pain and
extension movement after Colles' fracture, but the results
were not compared to a control group. Two other studies
of mobilisation after Colles' fracture found no significant
differences between outcomes of treatment and control
groups [32,33].
There is positive evidence to support the use of joint
mobilisation after acute ankle sprain [34,35]. Joint mobi-
lisation led to increased ankle movement, improved gait
patterns, reduced pain and the number of treatment ses-
sions required, and hastened return to activities when
compared with the usual rest, ice, compression and eleva-
tion protocol [35]. However, the effectiveness of joint
mobilisation after ankle fracture is less certain. Wilson
[36] conducted a randomised pilot study to investigate if
joint mobilisation plus whirlpool therapy and exercise
was more effective than whirlpool therapy and exercise
alone. Although an improvement in ankle movement and
function was reported when the treatment group was
compared to the control group, the difference between
groups was not statistically significant, potentially
because of the small sample size (n = 10).
The treatment cost of ankle fracture has been estimated in
studies from Britain and Canada [37,38], but to-date there
are no randomised controlled trials. In a retrospective
audit, costs of hospitalisation were significantly greater in
those who were operated on within 24 hours, compared
to those who were operated on more than 24 hours after
presentation [37]. The average extra cost per patient was
£990 (1998 British pounds). A prospective pilot study
reported that the total hospitalisation and outpatient
medical costs were $2,134 (United States dollars) per
patient over a 12-month period [38]. But this study did
not include a control group, and hence no comparisons of
costs or quality of life measures. Neither of these studies
assessed utilisation of services or included the cost of out-
patient physiotherapy. Only one published study has
reported an economic analysis of joint mobilisation [39],
but the comparisons made were between high-grade and
low-grade mobilisation for the shoulder. Therefore,
despite the common use of joint mobilisation as a treat-
ment technique, its current use after ankle fracture is
based on clinical experience and limited evidence of effec-
tiveness and cost-effectiveness.
The primary aim of this trial is to determine whether add-
ing joint mobilisation to an exercise programme is more
effective and cost-effective than exercise alone after cast
immobilisation for ankle fracture in adults. A secondary
aim is to determine if treatment effects are influenced by
fracture severity.
Methods
Design
This will be an assessor-blinded, multi-centre, ran-
domised controlled trial (Figure 1). Participants will be
stratified by site and randomly allocated in permuted
blocks to treatment or control groups. The randomisation
sequence will be generated a priori using the random
number function in Excel by an independent investigator
not directly involved in the assessment and treatment of
participants. Allocations will be sealed in opaque and
consecutively numbered envelopes, which will be opened
in sequence by the treating physiotherapist after the
recruitment and baseline assessment of each participant.BMC Musculoskeletal Disorders 2006, 7:46 http://www.biomedcentral.com/1471-2474/7/46
Page 3 of 10
(page number not for citation purposes)
Participants
Participants will be recruited following cast removal from
the plaster clinics and physiotherapy departments of three
large teaching hospitals in Sydney, Australia (Royal North
Shore Hospital, Royal Prince Alfred Hospital, and St Vin-
cent's Public Hospital). The inclusion criteria will be:
• ankle fracture treated with cast immobilisation with or
without surgical fixation
• cast removed in the preceding seven days
• approval from the orthopaedic specialist to weight-bear
as tolerated or partial weight-bear
• referral to outpatient physiotherapy for treatment
• at least 2 out of 10 pain in the ankle when up to 50% of
body weight is borne through the affected leg
• completed skeletal growth assessed by the union of epi-
physes on radiographs
• no concurrent and significant injuries or pathologies
which may affect the recovery of the participant's lower
limb function, and
• available for the six month follow-up period.
In addition to recruiting from multiple sites, other strate-
gies will be used to maximise recruitment rates [40]. A log
will be designed to aid the screening of potential partici-
pants at each site, and will be monitored by the investiga-
tors. Posters about the trial, inservices and regular
communication with the participating physiotherapy
departments will also assist to facilitate recruitment rates.
Ethical approval will be obtained from the ethics commit-
tee of each participating site (i.e., the University of Sydney
Human Research Ethics Committee, Northern Sydney
Health Human Research Ethics Committee, Sydney South
West Area Health Service Ethics Review Committee
(RPAH zone), and the St Vincent's Hospital Human
Research Ethics Committee).
Interventions
Interventions will be delivered by registered physiothera-
pists, who will receive training to provide treatments in
accordance with the experimental protocol.
Participants in the treatment group will receive passive joint
mobilisation (see Figure 2). The joint mobilisation tech-
nique used will be the anterior-posterior glide of the talus
[23]. The participant will be positioned in supine or long
sitting, with the affected ankle moved to the end of the
available range of pain-free dorsiflexion. The physiothera-
pist will manually apply large amplitude oscillatory
movements into resistance (i.e., Grade III [23]) in an ante-
rior-posterior direction on the talus for three sets of 60
seconds. This can be progressed by increasing the force
and repetitions (up to five sets of 60 seconds) of the mobi-
lisation, and the degree of ankle dorsiflexion. The choice
of this technique is based on findings of a previous study,
which showed that the anterior-posterior glide of the talus
was more effective than usual care after ankle sprain [35].
Participants in both the treatment and control groups will
be given an exercise programme that they will continue at
home. Exercises will be chosen from a standardised set of
exercises to ensure consistency. The exercises have been
Passive joint mobilisation Figure 2
Passive joint mobilisation. The joint mobilisation technique 
used will be the anterior-posterior glide of the talus. The 
physiotherapist will apply large amplitude oscillatory move-
ments into resistance (i.e., Grade III) on the talus.
Experimental protocol Figure 1
Experimental protocol.
Recruitment
È
Baseline assessment (within 7 days of cast removal) 
È
Randomisation and concealed allocation (point of entry into trial) 
ÈÈ
Exercise only 
(control group; n = 45) 
Exercise plus joint mobilisation 
(treatment group; n = 45) 
ÈÈ
4-week follow-up assessment and economic survey 
È
8-week economic survey (postal)
È
12-week follow-up assessment and economic survey 
È
16-week and 20-week economic survey (postal) 
È
24-week follow-up assessment and economic survey BMC Musculoskeletal Disorders 2006, 7:46 http://www.biomedcentral.com/1471-2474/7/46
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developed following consultation with physiotherapists
at the recruiting hospitals and are based on the pro-
gramme used in a previous study [41]. Three categories of
exercise will be prescribed: ankle mobility and strengthen-
ing exercise, stepping exercise, and weight bearing and
balancing exercise (see Figure 3). Participants will perform
one exercise from each category at any one time. The treat-
ing physiotherapist will be responsible for the progression
of the exercise programme, so the exercises will be tailored
to the individual participant's needs and will always be
challenging and difficult when repeated 10 times. Partici-
pants will be given exercise cards and exercise recording
sheets to record the number of repetitions performed each
day. The recommended frequency for most exercises will
be three sets of 10 repetitions per exercise per day.
In this pragmatic trial, participants will be seen at a fre-
quency typical to that which occurs in the clinical setting.
Participants in the treatment group will receive two treat-
ment sessions per week for four weeks for joint mobilisa-
tion and progression of the exercise programme.
Participants allocated to the control group will receive two
treatment sessions in the first week, then one session per
week for three weeks. In the first session, participants in
the control group will be taught the exercises, which will
be monitored and progressed in subsequent sessions.
In addition, at the treatment sessions all participants will
receive gait retraining, progression of walking aids, and
advice on prognosis and return to activities. If required,
participants will receive ice for pain relief, and compres-
sion and elevation for the management of swelling. No
other physiotherapy treatments will be administered dur-
ing the four-week intervention period.
After each initial treatment session, the treating physio-
therapist will receive a phone call from an investigator
unblinded to group allocation. Implementation of the
experimental protocol for each participant will be dis-
cussed to ensure compliance.
At the end of the intervention period, passive joint mobi-
lisation treatment will cease and participants will be
allowed to be progressed to exercises other than those in
the standardised set. Ankle taping can be performed to
assist return to sports.
The timing of discharge will not be dictated in the proto-
col. Participants will be discharged by their physiothera-
pists when they return to their previous level of function,
reach a plateau in their progress, or choose to discontinue
treatment.
Outcome assessment
Participants will be assessed at baseline and the four, 12,
and 24 week follow-up sessions by an assessor blinded to
group allocation. The physiotherapists, participants and
investigators will be asked to avoid giving information
which may reveal group allocation to the blinded asses-
sor. Assessor blinding will be checked after each follow-up
assessment. The assessor will be asked if he/she was
unblinded and will guess the allocation of each partici-
pant.
Demographic information will be collected and an X-ray
assessment will be carried out by the blinded assessor at
the baseline assessment. The X-ray assessment will deter-
mine the angle at which the fractured ankle was immobi-
lised and the number of malleoli involved, in order to
investigate the relationships between the angle of immo-
bilisation and fracture severity with outcome.
The primary outcomes will be activity limitation and
quality of life. They will be measured by the Lower
Extremity Functional Scale [42] and the Assessment of
Quality of Life scale [43], respectively. On the Lower
Extremity Functional Scale, participants will rate the diffi-
culty they have in performing 20 activities on a five-point
scale from zero (extreme difficulty or unable to perform
activity) to four (no difficulty). The maximum score is 80
points and a higher score denotes less limitation in activ-
ity. When tested in a sample of participants with lower
limb injuries that included ankle fracture, the scale
showed high internal consistency (alpha = 0.96) and test-
retest reliability (intraclass correlation coefficient = 0.86),
and correlated well with the physical component of the
Short Form 36 [42]. The Lower Extremity Functional Scale
is capable of discriminating between patients requiring
walking aides and patients not requiring walking aides,
and has moderate correlations with weight-bearing status
and ankle movement [44].
The Assessment of Quality of Life is designed to measure
health-related quality of life, and has 15 questions cover-
ing five dimensions: illness, independent living, social
relationships, physical senses and psychological wellbe-
ing [43]. It has high internal consistency (alpha = 0.81)
[43]. The Assessment of Quality of Life is sensitive to
changes in health states and is highly correlated with
other commonly-used quality of life scales [46]. Popula-
tion norms have been calculated for the Australian popu-
lation [46].
Twelve secondary outcome measures will be used (Table
1). All participants will be given a calendar on which to
mark the first day they can walk pain-free for 10 metres at
a comfortable cadence. This will be used to calculate the
number of days to pain-free walking from cast removal.BMC Musculoskeletal Disorders 2006, 7:46 http://www.biomedcentral.com/1471-2474/7/46
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Walking speed and step length asymmetry will be meas-
ured as the participants walk unaided along a 14-metre
walkway. The average of three attempts will be used for
data analysis. Participants will be instructed to walk as fast
and as well as possible. Their time to walk the central 10
metres will be recorded by a stop watch, and walking
speed will be calculated by dividing the distance covered
by the time elapsed. A six-metre long, one-metre wide mat
marked with five-centimetre grids will be taped to the
floor over the central six metres of the walkway. Partici-
pants will be videotaped as they walk across the mat. Step
length asymmetry (i.e., the difference in step length
between the affected and unaffected sides) will be calcu-
lated by playing the video recording in slow motion, and
digitising the heel position of each footfall on a custom-
ised computer programme [47]. This method has high
inter-rater, intra-rater and concurrent reliability [47-50].
Stepping rate on stairs will be calculated by the partici-
pants climbing four steps three times as fast as possible
without using handrails. This task is part of the Motor
Assessment Scale [51]. Although its psychometric proper-
ties have not been examined in people with musculoskel-
etal complaints, stair climbing will be included as an
outcome measure as it is reasonably challenging and is a
commonly-performed activity.
The home exercise programme Figure 3
The home exercise programme. Participants will perform one exercise from each category of exercise. The physiotherapist 
will be responsible for the prescription, instruction, monitoring, and progression of the exercises.
Ankle mobility &
strengthening exercises
Stepping exercises Weight bearing & 
balancing exercises 
E
a
s
i
e
s
t Theraband exercises Stepping forward and backward 
with affected foot (standing on 
affected foot) 
Taking as much 
weight on unaffected 
foot as possible 
Heel raises on both feet  Step-ups: affected foot on step, 
unaffected foot stepping from
ground to step and back 
Standing on affected 
leg only 
Heel raises with unaffected 
foot on a chair, affected foot 
on the ground 
Standing on affected 
leg with eyes closed 
Heel raises standing on 
affected foot 
Lateral stepping: affected foot on 
step with medial border of foot 
parallel to edge of step. Unaffected 
foot stepping sideways from ground 
to step and back
Standing on affected 
leg on foam 
P
r
o
g
r
e
s
s
i
o
n
H
a
r
d
e
s
t Heel raises standing on 
affected foot on a step 
Step-downs: affected foot on step, 
unaffected foot stepping forward off 
step to ground and back 
Standing on affected 
leg on foam with eyes 
closedBMC Musculoskeletal Disorders 2006, 7:46 http://www.biomedcentral.com/1471-2474/7/46
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Ankle dorsiflexion range of motion will be measured
using the weight-bearing lunge method [52]. Participants
will stand with the affected foot on the ground and the
great toe against the wall, and will bend the knee to touch
the wall. If the knee cannot reach the wall, the minimum
distance between the knee and the wall without the heel
lifting will be recorded in millimetres as a negative value.
If the knee can touch the wall, the foot will be gradually
moved back and the maximum distance between the great
toe and the wall without the heel lifting will be recorded
in millimetres as a positive value. Measured this way,
ankle dorsiflexion at the time of cast removal has been
shown to be a significant predictor of disability, perceived
change in symptoms and active ankle dorsiflexion range
six weeks and six months after ankle fracture [14]. The
weight bearing lunge method has high inter-rater and
intra-rater reliability (intraclass correlation coefficient
0.99 and 0.97 to 0.98 respectively) in the healthy popula-
tion [52].
Pain on standing with equal weight distribution and dur-
ing stair descent will be measured using a 100-mm visual
analogue scale, labelled "no pain" on one end and "worst
pain ever" on the other. The pain visual analogue scale
correlates positively with other self-reported measures of
pain intensity [53,54]. It has high test-retest reliability
(intraclass correlation coefficient = 0.71 to 0.99) [53], and
is highly responsive in detecting change [54]. Participants
will also rate their return to usual work, and return to
usual sport and leisure activities using a 100-mm visual
analogue scale, marked "not participating at all" at one
end and "return to full level" at the other.
Global perceived effect of treatment will be measured on
an 11-point scale, where participants rate their change in
symptoms from -5 (vastly worse) to +5 (completely recov-
ered). A scale of this kind is the most frequently used
external criterion to which score changes on other out-
come measurements are compared [42,55-57]. However
its use as an external criterion is under debate [58,59], and
there is little information regarding its validity and relia-
bility [59].
Satisfaction with physiotherapy treatment will be meas-
ured at the four-week follow-up assessment on a 100-mm
visual analogue scale marked "completely unsatisfactory"
at one end and "best possible" at the other. At all follow-
up assessments, participants will be asked if the physio-
therapy treatment has had any negative effects and, if so,
the nature of the effects. They will also record whether
they have had treatment other than physiotherapy for the
fractured ankle.
The treating physiotherapist will complete a survey for
every participant at each follow-up assessment until dis-
charge. Information gathered on this survey will be: the
date and reason of discharge (if applicable), number of
physiotherapy sessions scheduled, number of physiother-
apy sessions attended, exercises prescribed and repetitions
completed, any other physiotherapy treatment adminis-
tered, and, for the treatment group only, the dates,
number of sets and duration of the joint mobilisation
treatment. This information will be analysed to obtain the
length of physiotherapy required, percentage of scheduled
sessions attended, compliance of participants to the exer-
cise programme, and compliance of physiotherapists to
the experimental protocol.
Data will be collected on paper forms and manually
entered into a computer programme. Several strategies
will be implemented to ensure the accuracy of the data.
Data collection forms will be checked for completion.
Data entry will be performed twice and the two entries
will be compared to check for errors. Range checks will be
performed on outcome values at the completion of data
entry.
Economic analysis
The economic analysis will be conducted from the per-
spective of the Australian healthcare system and the indi-
Table 1: Secondary outcome measures
Number of days to pain-free walking
Measures of activity limitation: Unaided walking speed
Step length asymmetry during unaided walking
Stepping rate on stair climbing
Measures of impairments: Ankle dorsiflexion range of motion
Pain on standing with equal weight distribution
Pain on stair descent
Measures of participation: Return to usual work
Return to sport and leisure activities
Global perceived effect of treatment
Satisfaction with physiotherapy treatment
Negative effects of physiotherapy treatmentBMC Musculoskeletal Disorders 2006, 7:46 http://www.biomedcentral.com/1471-2474/7/46
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vidual patient, with data collected in a survey every four
weeks from the end of the four-week intervention period
to the 24-week follow-up assessment. Participants will
record all out-of-pocket expenses incurred due to the frac-
tured ankle, including the frequency and costs associated
with physiotherapy, other health and hospital services,
and the costs of medication. Figure 4 indicates the type of
resources which will be captured, the sources of data, and
proposed methods of valuation. At the four-week follow-
up assessment, participants will also be asked to provide
socio-demographic information such as their usual main
activity, normal annual household income, the type of
private health insurance they have (if any), and whether
they are renting, boarding or owners of their homes.
Statistical analysis
Data analysis will be undertaken at the completion of data
acquisition and will be by intention to treat (that is, par-
ticipants will be analysed according to group allocation
regardless of compliance) [60]. Missing data will be
replaced by the last known value carried forward. The stat-
istician will be given coded data to ensure blinding.
Separate analyses will be performed on the four, 12 and
24 week data, with the four-week (i.e., the end of the inter-
vention period) follow-up being the primary time point
for analysis. To test the effects of treatment, between-
group differences will be examined with analysis of covar-
iance using a regression approach. The emphasis will be
Economic evaluation Figure 4
Economic evaluation
Type of Resource  Source of data  Method of valuation 
Physiotherapy costs  Experimental protocol 
and observation in the 
hospital settings
Salary rates and on-costs for 
physiotherapists
Equipment Experimental protocol Manufacturer’s price 
(depreciated over 3 years) 
Participants’ out-of-pocket costs for 
interventions or medication in relation to 
the ankle fracture 
4-weekly surveys over 24 
weeks
Actual costs to participants
and cost to the Australian 
health system 
Use of other healthcare resources in 
relation to the ankle fracture (e.g. visits to 
specialists and alternative health services)
4-weekly surveys over 24 
weeks
Actual costs to participants
and cost to the Australian 
health system BMC Musculoskeletal Disorders 2006, 7:46 http://www.biomedcentral.com/1471-2474/7/46
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on estimation, but hypothesis tests will also be conducted
(alpha = 0.05). Pre-test scores will be entered into the
model as the only covariate.
In a secondary analysis designed to test the influence of
fracture severity on treatment effects, additional terms
(fracture severity, group by fracture severity interaction)
will be entered into the regression model. Fracture severity
will be categorised into two levels based on the number of
malleoli involved: less severe (unimalleolar fractures) and
more severe (bimalleolar or trimalleolar fractures). The
effect of fracture severity on treatment will be determined
by examining the interactions between group of alloca-
tion and fracture severity.
Ninety participants (45 per group) will participate in the
trial. This sample size provides a 90% probability of
detecting a difference between group means of 10 points
on the Lower Extremity Functional Scale, assuming a
standard deviation of 12 based on a recently published
study [41]. These calculations assume a correlation of 0.6
between pre- and post-test measures and an alpha of 0.05,
and allowed for 10% dropouts and 20% non-compliance.
The economic evaluation will consist of cost-effectiveness
and cost-utility analyses. The cost-effectiveness analysis
will use the Lower Extremity Functional Scale as a measure
of effectiveness. The cost-utility analysis will use the
Assessment of Quality of Life as a measure of utility [43].
The analyses will examine differences between treatment
and control participants in terms of costs incurred and
reductions in perceived disability (cost-effectiveness anal-
ysis) or utility gained (cost-utility analysis).
The incremental cost-effectiveness (utility) ratio (ICER)
will be calculated as: ICER = (CE - CC)/(UE - UC), where C
is average cost, U is the average effectiveness or utility
score, and subscripts E and C denote the treatment and
control arms. Joint mobilisation can be said to be cost-
effective relative to exercise alone if it produces less per-
ceived disability and/or greater utility at a lower cost, or
the cost per disability avoided or per quality of life gained
(i.e., the ICER) is less than some threshold value (e.g.,
$50,000 in Australian dollars). Sensitivity analysis will be
undertaken to explore the robustness and validity of the
results. That is, both costs and outcomes will be varied in
line with results from similar studies reported in the liter-
ature and the upper and lower bounds of the results from
this trial.
Funding
The trial is funded by the Motor Accidents Authority of
New South Wales, Australia (grant reference number 04/
241).
Discussion
The primary aim of this randomised controlled trial is to
determine the effectiveness and cost-effectiveness of pas-
sive joint mobilisation, in addition to an exercise pro-
gramme, in adults after cast immobilisation for ankle
fracture. The trial incorporates design features known to
minimise bias [62]. Participants will be assigned to treat-
ment or control groups using a concealed random proce-
dure. Assessments will be blinded. Data analysis will also
be blinded and by intention to treat.
Blinding confers several potential benefits to the rigor of
randomised controlled trials, particularly minimising bias
[61,62]. Failure to implement blinding could lead to
inflated estimates of effects [62,63]. The nature of the
treatments involved in this trial means that blinding of
the physiotherapists and participants is not possible. Nev-
ertheless, satisfaction with physiotherapy will be evalu-
ated as a means to assess participants' perception of the
treatment received.
A pragmatic trial design has been chosen as it can directly
inform clinical practice [, , , ]. The inclusion criteria of the
trial reflect the variety in patient presentations that would
be encountered by physiotherapists in the clinical setting.
The experimental protocol also simulates clinical practice.
Participants will be treated with the same frequency and
for the same duration as would be normal practice, and
one form of treatment (joint mobilisation plus exercise)
will be compared to another form of treatment (exercise
only), instead of placebo. The outcome measures chosen
are clinically oriented and participants will be analysed
according to group allocation regardless of compliance.
Using a pragmatic design broadens the generalisability of
the results. An added advantage to this trial is that the
pragmatic design allows a realistic economic evaluation of
the two treatment alternatives [65].
It is anticipated that data acquisition will finish by early
2007. Results from this trial will contribute to evidence-
based guidelines for rehabilitation after ankle fracture.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
AM, KR, MH and RH conceived and designed the trial pro-
tocol, and procured funding. MH designed the economic
analysis. RH designed the statistical analysis. CL refined
and developed the trial protocol. CL implemented the
trial protocol, managed the trial, performed blinded out-
come assessment and data entry, and drafted the manu-
script. AM, KR, MH and RH contributed to theBMC Musculoskeletal Disorders 2006, 7:46 http://www.biomedcentral.com/1471-2474/7/46
Page 9 of 10
(page number not for citation purposes)
manuscript. All authors read and approved the final man-
uscript.
Acknowledgements
This trial is funded by the Motor Accidents Authority of New South Wales, 
Australia. The authors would like to acknowledge the associate investiga-
tors of the trial: Trish Evans and Deborah Taylor at Royal North Shore 
Hospital, Sandeep Gupta and Louise Shaw at Royal Prince Alfred Hospital, 
and Steve Bradley and Bruce Donald at St Vincent's Public Hospital. The 
authors are grateful to the trial participants and the physiotherapy depart-
ments at Royal North Shore Hospital, Royal Prince Alfred Hospital, and St 
Vincent's Public Hospital, particularly: Craig Gregory, Carmel Bertuccio, 
Julie Penn, Nick Green and Michelle Skeed.
References
1. Whittle PA, Wood GW: Fractures of lower extremity.  In Camp-
bell's operative orthopaedics Volume 3. 10th edition. Edited by: Canale
ST. Philadelphia, Mosby; 2003:2725-2872. 
2. Michelson JD: Current concepts review. Fractures about the
ankle.  The Journal of bone and joint surgery American volume 1995, 77-
A:142-152.
3. Donatto KC: Ankle fractures and syndesmosis injuries.  Orthop
Clin North Am 2001, 32:79-90.
4. Lesic A, Bumbasirevic M: Ankle fractures.  Curr Orthop 2004,
18:232-244.
5. Bengner U, Johnell O, Redlund-Johnell I: Epidemiology of ankle
fracture 1950 and 1980. Increasing incidence in elderly
women.  Acta Orthop Scand 57(1):35-7 1986.
6. Court-Brown CM, McBirnie J, Wilson G: Adult ankle fractures -
an increasing problem?  Acta Orthop Scand 69(1):43-7 1998,
69:43-47.
7. Daly PJ, Fitzgerald RHJ, Melton LJ, Ilstrup DM: Epidemiology of
ankle fractures in Rochester, Minnesota.  Acta Orthopaedica
Scandinavica 1987, 58:539-544.
8. Jensen SL, Andresen BK, Mencke S, Nielsen PT: Epidemiology of
ankle fractures: a prospective population-based study of 212
cases in Aalborg, Denmark.  Acta Orthop Scand 1998, 69:48-50.
9. Lash N, Horne G, Fielden J, Devane P: Ankle fractures: functional
and lifestyle outcomes at 2 years.  ANZ Journal of Surgery 2002,
72:724-730.
10. Ward EG, Bodiwala GG, Thomas PD: The importance of lower
limb injuries in car crashes when cost and disability are con-
sidered.  Accident; Analysis and Prevention 1992, 24:613-620.
11. Solomon L, Warwick D, Nayagam S: Principles of fractures.  In
Apley's system of orthopaedics and fractures 8th edition. London,
Arnold; 2001:539-582. 
12. Solomon L, Warwick D, Nayagam S: Injuries of the ankle and
foot.  In Apley's system of orthopaedics and fractures 8th edition. Lon-
don, Arnold; 2001:733-759. 
13. Bewes PC: The management of ankle fractures.  Trop Doct 1995,
25:58-62.
14. Hancock MJ, Herbert RD, Stewart M: Prediction of outcome
after ankle fracture.  J Orthop Sports Phys Ther 2005, 35:786-792.
15. Broos PL, Bisschop AP: Operative treatment of ankle fractures
in adults: correlation between types of fracture and final
results.  Injury 1991, 22:403-406.
16. Chesworth BM, Vandervoort AA: Comparison of passive stiff-
ness variables and range of motion in uninvolved and
involved ankle joints of patients following ankle fractures.
Physical Therapy 1995, 75:253-261.
17. Shaffer MA, Okereke E, Esterhai JLJ, Elliott MA, Walker GA, Yim SH,
Vandenborne K: Effects of immobilization on plantar-flexion
torque, fatigue resistance, and functional ability following an
ankle fracture.  Physical Therapy 2000, 80:769-780.
18. Stevens JE, Walter GA, Okereke E, Scarborough MT, Esterhai JL,
George SZ, Kelley MJ, Tillman SM, Gibbs JD, Elliott MA, Frimel TN,
Gibbs CP, Vandenborne K: Muscle adaptations with immobiliza-
tion and rehabilitation after ankle fracture.  Med Sci Sports Exerc
36(10):1695-701 2004.
19. Vandenborne K, Elliott MA, Walter GA, Abdus S, Okereke E, Shaffer
M, Tahernia D, Esterhai JL: Longitudinal study of skeletal muscle
adaptations during immobilization and rehabilitation.  Muscle
& Nerve 1998, 21:1006-1012.
20. Belcher GL, Radomisli TE, Abate JA, Stabile LA, Trafton PG: Func-
tional outcome analysis of operatively treated malleolar
fractures.  J Orthop Trauma 11(2):106-9 1997, 11:106-109.
21. Nilsson G, Nyberg P, Ekdahl C, Eneroth M: Performance after sur-
gical treatment of patients with ankle fractures - 14-month
follow-up.  Physiother Res Int 2003, 8:69-82.
22. Ponzer S, Nasell H, Bergman B, Tornkvist H: Functional outcome
and quality of life in patients with Type B ankle fractures: a
two-year follow-up study.  J Orthop Trauma 13(5):363-8 1999.
23. Maitland GD: Peripheral manipulation.  3rd edition. London, Bos-
ton, Butterworth-Heinemann; 1991. 
24. Lederman E: Fundamentals of manual therapy.  N e w  Y o r k ,
Churchill Livingstone; 1997. 
25. Refshauge KM: Selection of treatment for musculoskeletal
conditions.  In Musculoskeletal physiotherapy: clinical science and evi-
dence-based practice 2nd edition. Edited by: Refshauge KM and Gass
EM. Oxford, Butterworth-Heinemann; 2004:245-275. 
26. Sluka KA, Wright A: Knee joint mobilization reduces secondary
mechanical hyperalgesia induced by capsaicin injection into
the ankle joint.  European Journal of Pain 2001, 5:81-87.
27. Paungmali A, O'Leary S, Souvlis T, Vicenzino B: Naloxone fails to
antagonize initial hypoalgesic effect of a manual therapy
treatment for lateral epicondylalgia.  Journal of Manipulative &
Physiological Therapeutics 2004, 27:180-185.
28. Paungmali A, O'Leary S, Souvlis T, Vicenzino B: Hypoalgesic and
sympathoexcitatory effects of mobilization with movement
for lateral epicondylalgia.  Physical Therapy 2003, 83:374-383.
29. Simon R, Vicenzino B, Wright A: The influence of an anteropos-
terior accessory glide of the glenohumeral joint on measures
of peripheral sympathetic nervous system function in the
upper limb.  Manual Therapy 1997, 2:18-23.
30. Randall T, Portney L, Harris BA: Effects of joint mobilization on
joint stiffness and active motion of the metacarpal-phalan-
geal joint.  J Orthop Sports Phys Ther 1992, 16:30-36.
31. Coyle JA, Robertson VJ: Comparison of two passive mobilizing
techniques following Colles' fracture: a multi-element
design.  Manual Therapy 1998, 3:34-41.
32. Taylor NF, Bennell KL: The effectiveness of passive joint mobi-
lisation on the return of active wrist extension following
Colles' fracture: a clinical trial.  New Zealand Journal of Physiother-
apy 1994, 22:24-28.
33. Kay S, Haensel N, Stiller K: The effect of passive mobilisation fol-
lowing fractures involving the distal radius: a randomised
study.  Australian Journal of Physiotherapy 2000, 46:93-101.
34. van der Wees PJ, Lenssen AF, Hendricks EJM, Stomp DJ, Dekker J, de
Bie RA: Effectiveness of exercise therapy and manual mobili-
sation in acute ankle sprain and functional instability: A sys-
tematic review.  Australian Journal of Physiotherapy 2006, 52:27-37.
35. Green T, Refshauge K, Crosbie J, Adams R: A randomized control-
led trial of a passive accessory joint mobilization on acute
ankle inversion sprains.  Physical Therapy 2001, 81:984-994.
36. Wilson FM: Manual therapy versus traditional exercises in
mobilisation of the ankle post-ankle fracture: a pilot study.
New Zealand Journal of Physiotherapy 1991, 19:11-16.
37. James LA, Sookhan N, Subar D: Timing of operative intervention
in the management of acutely fractured ankles and the cost
implications.  Injury 2001, 32:469-472.
38. Bhandari M, Sprague S, Ayeni OR, Hanson BP, Moro JK: A prospec-
tive cost analysis following operative treatment of unstable
ankle fractures: 30 patients followed for 1 year.  Acta Orthopae-
dica Scandinavica 2004, 75:100-105.
39. van den Hout WB, Vermeulen HM, Rozing PM, Vlieland TP: Impact
of adhesive capsulitis and economic evaluation of high-grade
and low-grade mobilisation techniques.  Australian Journal of
Physiotherapy 2005, 51:141-149.
40. Lovato LC, Hill K, Hertert S, Hunninghake DB, Probstfield JL:
Recruitment for controlled clinical trials: literature sum-
mary and annotated bibliography.  Controlled Clinical Trials 1997,
18:328-352.
41. Moseley AM, Herbert RD, Nightingale EJ, Taylor DA, Evans TM, Rob-
ertson GJ, Gupta SK, Penn J: Passive stretching does not
enhance outcomes in patients with plantarflexion contrac-
ture after cast immobilization for ankle fracture: A rand-Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Musculoskeletal Disorders 2006, 7:46 http://www.biomedcentral.com/1471-2474/7/46
Page 10 of 10
(page number not for citation purposes)
omized controlled trial.  Arch Phys Med Rehabil 2005,
86:1118-1126.
42. Binkley JM, Stratford PW, Lott SA, Riddle DL: The Lower Extrem-
ity Functional Scale (LEFS): scale development, measure-
ment properties, and clinical application. North American
Orthopaedic Rehabilitation Research Network.  Physical Ther-
apy 1999, 79:371-383.
43. Hawthorne G, Richardson J, Osborne R: The Assessment of Qual-
ity of Life (AQoL) instrument: a psychometric measure of
health-related quality of life.  Quality of Life Research 1999,
8:209-224.
44. Alcock GK, Stratford PW: Validation of the Lower Extremity
Functional Scale on athletic subjects with ankle sprains.  Phys-
iother Can 2002, 54:233-240.
45. Hawthorne G, Richardson J, Day NA: A comparison of the
Assessment of Quality of Life (AQoL) with four other
generic utility instruments.  Annals of Medicine 2001, 33:358-370.
46. Hawthorne G, Osborne R: Population norms and meaningful
differences for the Assessment of Quality of Life (AQoL)
measure.  Aust N Z J Public Health 2005:136-142.
47. Wall JC, Devlin J, Khirchof R, Lackey B: Measurement of step
widths and step lengths: a comparison of measurements
made directly from a grid with those made from a video
recording.  J Orthop Sports Phys Ther 2000, 30:410-417.
48. Gaudet G, Goodman R, Landry M, Russell G, Wall JC: Measure-
ment of step length and step width: a comparison of video-
tape and direct measurements.  Physiother Can 1990, 42:12-15.
49. van Loo MA, Moseley AM, Bosman JM, de Bie RA, Hassett L: Test-
re-test reliability of walking speed, step length and step
width measurement after traumatic brain injury: a pilot
study.  Brain Injury 2004, 18:1041-1048.
50. van Loo MA, Moseley AM, Bosman JM, de Bie RA, Hassett L: Inter-
rater reliability and concurrent validity of step length and
step width measurement after traumatic brain injury.  Disa-
bility and Rehabilitation 2003, 25:1195-1200.
51. Carr JH, Shepherd RB, Nordholm L, Lynne D: Investigation of a
new motor assessment scale for stroke patients.  Physical Ther-
apy 1985, 65:175-180.
52. Bennell K, Talbot RC, Wajswelner H, Techovanich W, Kelly DH, Hall
AJ: Intra-rater and inter-rater reliability of a weight-bearing
lunge measure of ankle dorsiflexion.  Australian Journal of Physio-
therapy 1998, 44:175-180.
53. Kahl C, Cleland JA: Visual analogue scale, numeric pain rating
scale and the McGill pain Questionnaire: an overview of psy-
chometric properties.  Phys Ther Rev 2005, 10:123-128.
54. von Korff M, Jensen MP, Karoly P: Assessing global pain severity
by self-report in clinical and health services research.  Spine
2000, 25:3140-3151.
55. Beurskens AJ, de Vet HC, Koke AJ: Responsiveness of functional
status in low back pain: a comparison of different instru-
ments.  Pain 1996, 65:71-76.
56. Hagg O, Fritzell P, Nordwall A, Swedish Lumbar Spine Study Group:
The clinical importance of changes in outcome scores after
treatment for chronic low back pain.  European Spine Journal
2003, 12:12-20.
57. Pengel LH, Refshauge KM, Maher CG: Responsiveness of pain, dis-
ability, and physical impairment outcomes in patients with
low back pain.  Spine 2004, 29:879-883.
58. Fritz JM, Irrgang JJ: A comparison of a modified Oswestry Low
Back Pain Disability Questionnaire and the Quebec Back
Pain Disability Scale.  Physical Therapy 2001, 81:776-788.
59. Norman GR, Stratford P, Regehr G: Methodological problems in
the retrospective computation of responsiveness to change:
the lesson of Cronbach.  J Clin Epidemiol 50(8):869-79 1997.
60. Hollis S, Campbell F: What is meant by intention to treat anal-
ysis? Survey of published randomised controlled trials.  BMJ
1999, 319:670-674.
61. Schulz KF, Chalmers I, Hayes RJ, Altman DG: Empirical evidence
of bias: dimensions of methodological quality associated with
estimates of treatment effects in controlled trials.  JAMA : the
journal of the American Medical Association 1995, 273:408-412.
62. Schulz KF, Grimes DA: Blinding in randomised trials: hiding
who got what.  Lancet 2002, 359:696-700.
63. Boutron I, Estellat C, Ravaud P: A review of blinding in rand-
omized controlled trials found results inconsistent and ques-
tionable.  Journal of Clinical Epidemiology 2005, 58:1220-1226.
64. Helms PJ: 'Real world' pragmatic clinical trials: what are they
and what do they tell us?  Pediatric allergy and immunology 2002,
13:4-9.
65. Macpherson H: Pragmatic clinical trials.  Complementary Therapies
in Medicine 2004, 12:136-170.
66. Roland M, Torgerson DJ: Understanding controlled trials: What
are pragmatic trials?  BMJ 1998, 316:285.
67. Tunis SR, Stryer DB, Clancy CM: Practical clinical trials. Increas-
ing the value of clinical research for decision making in clini-
cal and health policy.  JAMA : the journal of the American Medical
Association 2003, 290:1624-1632.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2474/7/46/prepub